Why Payers and Employers Invest in Second Opinions for High-Stakes Medical Decisions
When a patient faces a major diagnosis—like cancer, cardiac surgery, complex autoimmune disease, or neurological disorder—the treatment choices that follow are often life-changing and expensive. For insurers, these are the moments when clinical accuracy and cost discipline intersect most critically. That’s why forward-thinking employers and payers, including both traditional health insurers and stop-loss carriers, are increasingly investing in second medical opinion programs.
